Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 15.000 / 898.498K |
Day Range | - - - |
52 Wk Range | 22.110 - 53.180 |
Market Cap | $2.488B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 12.28% |
Days to Cover | 11.75 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.
Other companies in Celldex Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), TG Therapeutics (NASDAQ:TGTX) and ACADIA Pharmaceuticals (NASDAQ:ACAD).
The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by HC Wainwright & Co. on Wednesday, May 15, 2024. The analyst firm set a price target for 80.00 expecting CLDX to rise to within 12 months (a possible 111.92% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $37.75 last updated May 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Celldex Therapeutics.
Celldex Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Celldex Therapeutics.
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.